1. Home
  2. IMRN vs MARPS Comparison

IMRN vs MARPS Comparison

Compare IMRN & MARPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • MARPS
  • Stock Information
  • Founded
  • IMRN 1994
  • MARPS 1956
  • Country
  • IMRN Australia
  • MARPS United States
  • Employees
  • IMRN N/A
  • MARPS N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • MARPS Oil & Gas Production
  • Sector
  • IMRN Health Care
  • MARPS Energy
  • Exchange
  • IMRN Nasdaq
  • MARPS Nasdaq
  • Market Cap
  • IMRN 9.2M
  • MARPS 8.6M
  • IPO Year
  • IMRN N/A
  • MARPS N/A
  • Fundamental
  • Price
  • IMRN $1.86
  • MARPS $4.60
  • Analyst Decision
  • IMRN Strong Buy
  • MARPS
  • Analyst Count
  • IMRN 1
  • MARPS 0
  • Target Price
  • IMRN $5.00
  • MARPS N/A
  • AVG Volume (30 Days)
  • IMRN 55.1K
  • MARPS 6.7K
  • Earning Date
  • IMRN 08-29-2025
  • MARPS 01-01-0001
  • Dividend Yield
  • IMRN N/A
  • MARPS 7.81%
  • EPS Growth
  • IMRN N/A
  • MARPS N/A
  • EPS
  • IMRN N/A
  • MARPS 0.36
  • Revenue
  • IMRN $4,777,422.00
  • MARPS $1,036,019.00
  • Revenue This Year
  • IMRN N/A
  • MARPS N/A
  • Revenue Next Year
  • IMRN N/A
  • MARPS N/A
  • P/E Ratio
  • IMRN N/A
  • MARPS $12.65
  • Revenue Growth
  • IMRN 48.63
  • MARPS N/A
  • 52 Week Low
  • IMRN $1.50
  • MARPS $3.34
  • 52 Week High
  • IMRN $2.87
  • MARPS $7.90
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 56.87
  • MARPS 49.07
  • Support Level
  • IMRN $1.73
  • MARPS $4.59
  • Resistance Level
  • IMRN $1.89
  • MARPS $5.04
  • Average True Range (ATR)
  • IMRN 0.10
  • MARPS 0.20
  • MACD
  • IMRN 0.01
  • MARPS 0.01
  • Stochastic Oscillator
  • IMRN 76.77
  • MARPS 46.51

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About MARPS Marine Petroleum Trust Units of Beneficial Interest

Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.

Share on Social Networks: